Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)

19.21 +0.25 (+1.32%)
Streaming Delayed Price Updated: 10:36 AM EDT, Sep 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,723
Open 18.82
Bid (Size) 19.08 (1)
Ask (Size) 19.28 (1)
Prev. Close 18.96
Today's Range 18.50 - 19.24
52wk Range 13.30 - 30.03
Shares Outstanding 41,151,111
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's pre-market session
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
Enliven Posts Loss Beat and Cash Surge
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
-19.6%
-19.6%
1 Month
-7.9%
-7.9%
3 Month
-5.3%
-5.3%
6 Month
-14.5%
-14.5%
1 Year
-18.5%
-18.5%

More News

Read More
Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Enliven Short Interest Falls To 14-Month Low After Leukemia Trial Data, Goldman Initiates With ‘Buy’
Via Stocktwits
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
Via FinancialNewsMedia
Topics Artificial Intelligence
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Via Benzinga
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024
Via InvestorPlace
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
Via Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says
Via Benzinga
Wall Street Mixed As Tech Stocks Fall, Fed Meeting Begins
Via Talk Markets
Topics Economy
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
7 A-Rated Biotech Stocks for Your August Buy List
Via InvestorPlace
Bears Reload On Mobileye After Sharp Gains In Stock Price
Via Talk Markets

Frequently Asked Questions

Is Enliven Therapeutics, Inc. - Common Stock publicly traded?
Yes, Enliven Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Enliven Therapeutics, Inc. - Common Stock trade on?
Enliven Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enliven Therapeutics, Inc. - Common Stock?
The ticker symbol for Enliven Therapeutics, Inc. - Common Stock is ELVN on the Nasdaq Stock Market
What is the current price of Enliven Therapeutics, Inc. - Common Stock?
The current price of Enliven Therapeutics, Inc. - Common Stock is 19.21
When was Enliven Therapeutics, Inc. - Common Stock last traded?
The last trade of Enliven Therapeutics, Inc. - Common Stock was at 09/22/25 10:36 AM ET
What is the market capitalization of Enliven Therapeutics, Inc. - Common Stock?
The market capitalization of Enliven Therapeutics, Inc. - Common Stock is 790.51M
How many shares of Enliven Therapeutics, Inc. - Common Stock are outstanding?
Enliven Therapeutics, Inc. - Common Stock has 791M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.